홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 53396310생성일: 2026년 11월 3일

수16f

수16f · SU 16f · SU16f, 10 mM in DMSO · PDGFR Tyrosine Kinase Inhibitor VII · PDGFR Tyrosine Kinase Inhibitor VII - CAS 251356-45-3 - Calbiochem · (Z)-3-(2,4-Dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid · 5-[1,2-Dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoicacid · 1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-

https://huagongshe.com/ko/chemical/53396310

수16f 분자 구조식

식별자 및 물리적 특성

CAS No.251356-45-3
분자식C24H22N2O3
평균 분자량386.4 g/mol
단동위원소 질량386.16304257 g/mol
SMILESCc1[nH]c(C=C2C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O
InChIKeyAPYYTEJNOZQZNA-UHFFFAOYSA-N
PubChem CID53396310
DTXSIDDTXSID90694250
현지명수16f

화학 및 물리적 성질

XLogP3.9
극성 표면적82.2
수소 결합 공여자 수3
수소 결합 수용자 수3
회전 가능 결합 수5
무거운 원자 수29
형식 전하0
복잡도655
끓는 점661.7±55.0 °C(Predicted)
밀도1.292±0.06 g/cm3(Predicted)
저장 조건Store at RT
용해도Soluble to 100 mM in DMSO
물리적 상태진한 주황색 고체
pKa(산도 계수)4+-.0.10(Predicted)
색상Yellow to orange
InChI1S/C24H22N2O3/c1-14-18(10-11-23(27)28)15(2)25-21(14)13-20-19-9-8-17(12-22(19)26-24(20)29)16-6-4-3-5-7-16/h3-9,12-13,25H,10-11H2,1-2H3,(H,26,29)(H,27,28)/b20-13-
InChIKeyAPYYTEJNOZQZNA-MOSHPQCFSA-N

안전 및 규제

수질 위해 등급(WGK)WGK 1
저장 분류11 - Combustible Solids

용도

용도

SU 16f is used in the synthetic preparation of [(Dihydrooxoindolylidene)methyl]pyrrolepropanoic Acid as a tyrosine kinase inhibitor.

일반 설명

A cell-permeable indolinone compound that acts as a potent, ATP site-targeting PDGFR inhibitor (IC50 = 10 nM against PDGFRβ), while affecting Flk-1/KDR/ VEGFR2, FGFR1, and EGFR only at much higher concentrations (IC50 = 0.14, 2.29, and >100 μM, respectively). Reported to selectively inhibit PDGFβ- over EGF-stimulated proliferation in EGFR-expressing NIH 3T3 cultures (IC50 = 0.11 and 21.9 μM, respectively) and exhibit much weaker potency against the proliferation of HUVEC cells upon FGF or VEGF stimulation (IC50 = 10 μM).